Prevalence of Lynch syndrome in women with mismatch repair‐deficient ovarian cancer
Rachel Hodan(Cancer Institute (WIA)), Teri A. Longacre(Palo Alto University), James M. Ford(Palo Alto University), Allison W. Kurian(Stanford University), Kristina Cotter(Stanford University), Ann K. Folkins(Stanford University), Kerry Kingham(Cargill (Netherlands))
Cited by 17
Related Papers
A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging
|Cell|2018|1.2k
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer
|Clinical Cancer Research|2016|1.2k
Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2021|1.1k
A Population-Based Study of Genes Previously Implicated in Breast Cancer
|New England Journal of Medicine|2021|862
NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017
|Journal of the National Comprehensive Cancer Network|2016|660